CASE SERIES OF PATIENTS WITH CHRONIC NON-TUBERCULOSIS MYCOBACTERIA ACCOMPANYING WITH ANTI-INTERFERON GAMMA ANTIBODY

被引：0
|
作者：
Tsao, Y. P. [1 ]
机构：
[1] Taipei Vet Gen Hosp, Taipei, Taiwan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.6610
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1063
引用
收藏
页码：1817 / 1817
页数：1
相关论文
共 50 条
  • [41] Anti-interferon gamma (IFN gamma) antibody treatment inhibits cutaneous delayed-type hypersensitivity and crescent formation in anti-GEM glomerulonephritis (GN) in mice.
    Huang, XR
    Tipping, PG
    Holdsworth, SR
    KIDNEY INTERNATIONAL, 1997, 51 (04) : 1319 - 1319
  • [42] USE OF ANTI-INTERFERON BETA MONOCLONAL ANTIBODY FOR CASE OF MDA-5 DERMATOMYOSITIS AND ASSOCIATED INTERSTITIAL LUNG DISEASE
    Nasim, Rabab
    Palmon, Philip
    Nasim, Atif
    CHEST, 2021, 160 (04) : 1194A - 1194A
  • [43] Cervical abscess caused by Mycobacterium tilburgii in a patient carrying anti-interferon gamma autoantibody: A case report and literature review
    Shinohara, Koh
    Matsumura, Yasufumi
    Sakagami, Takuro
    Morioka, Shigefumi
    Yoshizawa, Kazutaka
    Aoki, Kazuaki
    Motobayashi, Hirofumi
    Tochitani, Kentaro
    Nagao, Miki
    Shimizu, Tsunehiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (05) : 699 - 704
  • [44] Innovative Approach for the Identification of an Appropriate Dose Regimen of a Targeted Treatment, NI-0501, an Anti-Interferon Gamma (IFNg) Antibody, in Patients with Hemophagocytic Lymphohistiocytosis (HLH)
    De Min, Cristina
    Jacqmin, Philippe
    Laveille, Christian
    Nelson, Robert
    Guilhot, Florence
    Deehan, Maureen
    Kosco-Vilbois, Marie
    Ferlin, Walter
    Lapeyre, Genevieve
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [45] Anti-Interferon gamma monoclonal antibody NI-0501: A new option to render allogeneic HSCT for HLH safer and more effective?
    Locatelli, F.
    Jordan, M.
    Allen, C.
    Cesaro, S.
    Fagioli, F.
    Henry, M.
    Rizzari, C.
    Rossig, C.
    Sevilla, J.
    Ballabio, M.
    Ferlin, W.
    De Min, C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S86 - S86
  • [46] Macrophage Activation Syndrome (MAS) in Systemic Juvenile Idiopathic Arthritis (sJIA): Treatment with Emapalumab, an Anti-Interferon Gamma (IFNγ) Monoclonal Antibody
    De Benedetti, Fabrizio
    Grom, Alexei A.
    Brogan, Paul
    Bracaglia, Claudia
    Pardeo, Manuela
    Marucci, Giulia
    Eleftheriou, Despina
    Papadopoulou, Charalampia
    Quartier, Pierre
    Anton, Jordi
    Frederiksen, Rikke
    Asnaghi, Veronica
    Ballabio, Mari
    Min, Cristinade
    BLOOD, 2021, 138
  • [47] Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
    Izadi, Nafiseh
    Derakhshan, Mohammad
    Samiei, Amin
    Ghazvini, Kiarash
    RESPIRATORY MEDICINE CASE REPORTS, 2015, 15 : 12 - 13
  • [48] Fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease
    Hommes, D. W.
    Mikhajlova, T. L.
    Stoinov, S.
    Stimac, D.
    Vucelic, B.
    Lonovics, J.
    Zakuciova, M.
    D'Haens, G.
    Van Assche, G.
    Ba, S.
    Lee, S.
    Pearce, T.
    GUT, 2006, 55 (08) : 1131 - 1137
  • [49] Macrophage activation syndrome with acute hepatitis in a patient with adult-onset immunodeficiency with anti-interferon gamma antibodies: a case report
    Hirsch, William
    Megna, Bryant
    Adeyi, Oyedele
    Lim, Nicholas
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [50] Macrophage Activation Syndrome (Mas) in Systemic Juvenile Idiopathic Arthritis (Sjia): Treatment with Emapalumab, an Anti-Interferon Gamma (Ifn.) Monoclonal Antibody
    De Benedetti, Fabrizio
    Grom, Alexei
    Brogan, Paul
    Bracaglia, Claudia
    Pardeo, Manuela
    Marucci, Giulia
    Eleftheriou, Despina
    Papadopoulou, Charalampia
    Quartier, Pierre
    Anton, Jordi
    Frederiksen, Rikke
    Asnaghi, Veronica
    Ballabio, Maria
    de Min, Cristina
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S4 - S4
12345